Curaleaf Holdings (CURLF) Net Equity Issued and Repurchased (2021)
Curaleaf Holdings (CURLF) posted quarterly Net Equity Issued and Repurchased of -$3000.0 for Q4 2021, down 200.0% quarter-over-quarter from $3000.0 in Q3 2021.
Curaleaf Holdings (CURLF) Net Equity Issued and Repurchased (2021) Analysis & Trends
Curaleaf Holdings' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at -$3000.0 for Q4 2021.
- In Q4 2021, Net Equity Issued and Repurchased changed N/A year-over-year to -$3000.0; the TTM figure through Dec 2021 stood at $240.6 million (changed N/A YoY), while the FY2023 annual figure was $11.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q4 2021 stood at -$3000.0, down from $3000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $240.6 million in Q1 2021, with the low at -$3000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -3,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 240.57 Mn |
| Mar 31, 2021 | 240.57 Mn |